A61B5/029

Bio-information measuring apparatus and bio-information measuring method

A bio-information measuring apparatus bio-information measuring method are provided. The bio-information measuring apparatus includes: a pulse wave obtainer configured to obtain a pulse wave signal, and a processor configured to correct a feature of the obtained pulse wave signal based on a variation in an amplitude of the obtained pulse wave signal, and to measure bio-information based on the corrected feature.

Determination of cardiac parameters for modulation of blood pump support

The systems, devices, and methods presented herein use a blood pump to obtain measurements of cardiac function. The system can quantify the functioning of the native heart by measuring certain parameters/signals such as aortic pressure or motor current, then calculate and display one or more cardiac parameters and heart function parameters, such as left ventricular pressure, left ventricular end diastolic pressure, or cardiac power output. These parameters provide valuable information to a user regarding current cardiac function, as well as positioning and function of the blood pump. In some embodiments, the system can act as a diagnostic and therapeutic tool. Providing cardiac parameters in real-time, along with warnings about adverse effects and recommendations to support cardiac function, such as increasing or decreasing the volumetric flow rate of blood pumped by the device, administering pharmaceutical therapies, and/or repositioning the blood pump allow clinicians to better support and treat cardiovascular disease.

Determination of cardiac parameters for modulation of blood pump support

The systems, devices, and methods presented herein use a blood pump to obtain measurements of cardiac function. The system can quantify the functioning of the native heart by measuring certain parameters/signals such as aortic pressure or motor current, then calculate and display one or more cardiac parameters and heart function parameters, such as left ventricular pressure, left ventricular end diastolic pressure, or cardiac power output. These parameters provide valuable information to a user regarding current cardiac function, as well as positioning and function of the blood pump. In some embodiments, the system can act as a diagnostic and therapeutic tool. Providing cardiac parameters in real-time, along with warnings about adverse effects and recommendations to support cardiac function, such as increasing or decreasing the volumetric flow rate of blood pumped by the device, administering pharmaceutical therapies, and/or repositioning the blood pump allow clinicians to better support and treat cardiovascular disease.

Interaction monitoring of non-invasive imaging based FFR

A system (100) includes a computer readable storage medium (122) with computer executable instructions (124), including: a biophysical simulator component (126) configured to determine a fractional flow reserve value via simulation and a traffic light engine (128) configured to track a user-interaction with the computing system at one or more points of the simulation to determine the fractional flow reserve value. A processor (120) is configured to execute the biophysical simulator component to determine the fractional flow reserve value and configured to execute the traffic light engine to track the user-interaction with respect to determining the fractional flow reserve value and provide a warning in response to determining there is a potential incorrect interaction. A display is configured to display the warning requesting verification to proceed with the simulation from the point, wherein the simulation is resumed only in response to the processor receiving the requested verification.

Interaction monitoring of non-invasive imaging based FFR

A system (100) includes a computer readable storage medium (122) with computer executable instructions (124), including: a biophysical simulator component (126) configured to determine a fractional flow reserve value via simulation and a traffic light engine (128) configured to track a user-interaction with the computing system at one or more points of the simulation to determine the fractional flow reserve value. A processor (120) is configured to execute the biophysical simulator component to determine the fractional flow reserve value and configured to execute the traffic light engine to track the user-interaction with respect to determining the fractional flow reserve value and provide a warning in response to determining there is a potential incorrect interaction. A display is configured to display the warning requesting verification to proceed with the simulation from the point, wherein the simulation is resumed only in response to the processor receiving the requested verification.

Device and method for liveness detection

A device for liveness detection is disclosed. The liveness detecting device has a simplest structure that principally comprises a light sensing unit and a signal processing module. Particularly, the signal processing module is configured for having a physiological feature extracting unit and a liveness detecting unit therein. The physiological feature extracting unit is adopted for extracting a first physiological feature from a PPG signal, or extracting a second physiological feature from the PPG signal that has been applied with a signal process. As such, through the first and second physiological features, the liveness detecting unit is able to determine whether a subject is a living body or not. The liveness detecting device does not use any camera unit and iPPG technology, such that the liveness detecting device has advantages of simple structure, low cost and immediately completing liveness detection.

Device and method for liveness detection

A device for liveness detection is disclosed. The liveness detecting device has a simplest structure that principally comprises a light sensing unit and a signal processing module. Particularly, the signal processing module is configured for having a physiological feature extracting unit and a liveness detecting unit therein. The physiological feature extracting unit is adopted for extracting a first physiological feature from a PPG signal, or extracting a second physiological feature from the PPG signal that has been applied with a signal process. As such, through the first and second physiological features, the liveness detecting unit is able to determine whether a subject is a living body or not. The liveness detecting device does not use any camera unit and iPPG technology, such that the liveness detecting device has advantages of simple structure, low cost and immediately completing liveness detection.

ESTIMATION OF MIXED VENOUS OXYGEN SATURATION
20220378323 · 2022-12-01 ·

The present disclosure relates to a method for continuous and noninvasive estimation of mixed venous blood saturation [SvO2] in a mechanically ventilated subject (3). The method comprises the steps of measuring (S1; S10) an expiratory carbon dioxide [CO2] content in expiration gas exhaled by the subject, measuring (S2; S20) an expiratory flow or volume of expiration gas exhaled by the subject, estimating (S3; S30) a cardiac output [CO] or an effective pulmonary blood flow [EPBF] of the subject from the measured expiratory CO2 content and the measured expiratory flow or volume using a capnodynamic Fick method, and estimating (S4; S40) SvO2 based on the estimated CO or the EPBF of the subject.

SYSTEMS, DEVICES, AND METHODS FOR MONITORING LOADS AND FORCES ON A SEAT
20220378373 · 2022-12-01 ·

Systems, devices, and methods are disclosed herein for monitoring physiological data of subjects seated on a toilet, including systems, devices, and methods for monitoring loads and forces on a toilet seat. In some embodiments, systems, devices, and methods disclosed herein include a set of sensors that can measure loads and forces present at coupling points between a toilet seat and a base or other components of a toilet.

Method to quantify the hemodynamic and vascular properties in vivo from arterial waveform measurements
11510585 · 2022-11-29 ·

Disclosed herein are in vivo non-invasive methods and devices for the measurement of the hemodynamic parameters and aortic valve conformance and compliance in a subject. The method requires measuring the peripheral pulse volume waveform (PVW), the peripheral pulse pressure waveform (PPW), and the peripheral pulse velocity waveform (PUW) from the same artery using a non-invasive device. The waveforms PPW and PUW are used to calculate the waveform dPdU which is used to determine aortic valve ejection volume, closure volume, and quality factor, as well as stroke volume and cardiac output. The disclosed methods and devices are useful in the diagnosis and treatment of aortic valve disease, disorders, and dysfunction.